COCH Stock Analysis: Buy, Sell, or Hold?
COCH - Envoy Medical, Inc. Class A Common Stock
$0.75
0.00 (-0.05%)
▼
5d:
-6.25%
30d:
+13.46%
90d:
+2.33%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When COCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: COCH shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: COCH shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: COCH is currently trading at $0.75, which is considered extended relative to its 30-day fair value range of $0.67 to $0.75.
Technical Outlook: Technically, COCH is in a uptrend. Immediate support is located at $0.66, while resistance sits at $0.81.
Market Sentiment: COCH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.25 (+200.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, COCH is in a uptrend. Immediate support is located at $0.66, while resistance sits at $0.81.
Market Sentiment: COCH scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $2.25 (+200.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.67 -
$0.75
Company Quality Score
36/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 200.0% below Wall St target ($2.25)
- WARNING: Composite score 36/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.67 -
$0.75
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.66
Resistance Level
$0.81
Current Trend
Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.33
Wall Street Target
$2.25
(+200.0%)
Revenue Growth (YoY)
-34.6%
Share & Embed Analysis
Last updated: August 23, 2026 2:13 AM ET
Data refreshes hourly during market hours. Next update: 3:13 AM
Data refreshes hourly during market hours. Next update: 3:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is COCH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 37 SELL |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
